Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial

被引：0

作者：

Huang, Yu ^{[1
]}

Lu, Hong ^{[1
]}

机构：

[1] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, NHC Key Lab Digest Dis, Shanghai Inst Digest Dis,Sch Med,Renji Hosp, Shanghai, Peoples R China

来源：

JOURNAL OF GASTROENTEROLOGY | 2024年 / 59卷 / 04期

关键词：

ERADICATION;

D O I：

10.1007/s00535-024-02085-z

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：358 / 358

页数：1

共 50 条

[21] Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial
Mei, Hao
Guo, Yan
Zhao, Jing-Tao
Yang, Jun
Sun, Wen-jing
Zhang, De-kui
He, Ping
Shi, Gang
Su, Na-yun
Han, Ran
Lan, Chun-Hui
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
[22] Optimization of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real-World Evidence Study
Huang, Yu
Qiu, Shuhan
Guo, Yixian
Chen, Jinnan
Li, Meixuan
Ding, Zhaohui
Zhang, Wei
Liang, Xiao
Lu, Hong
HELICOBACTER, 2024, 29 (05)
[23] Comparative study of allicin-containing quadruple therapy vs. bismuth-containing quadruple therapy for the treatment of Helicobacter pylori infection: a prospective randomized study
Li, Huan
Xia, Xiu-Juan
Zhang, Lin-Fang
Chi, Jing-Shu
Liu, Peng
Wu, Hao
Xie, Xiao-Ran
Tian, De-Lin
Kun, Kai-Xiao
Gong, Ren-Jie
Liu, Xiao-Ming
Xu, Can-Xia
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (02) : 194 - 200
[24] A meta-analysis of randomized controlled trials of bismuth-containing quadruple therapy combined with probiotic supplement for eradication of Helicobacter pylori
司小北
China Medical Abstracts(Internal Medicine), 2017, 34 (04) : 208 - 209
[25] Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial
Cho, Jun-Hyung
Jin, So Young
Park, Suyeon
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (06) : 923 - 929
[26] HELICOBACTER PYLORI ERADICATION A new, single-capsule bismuth-containing quadruple therapy
Gisbert, Javier P.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (06) : 307 - 309
[27] First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy
Tarhini, Mandi
Fayyad-Kazan, Mohammad
Fayyad-Kazan, Hussein
Mokbel, Mahmoud
Nasreddine, Mohammad
Badran, Bassam
Kchour, Ghada
MICROBIAL PATHOGENESIS, 2018, 117 : 23 - 26
[28] First-line treatment of helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy
Tarhini, M.
Fayyad-Kazan, M.
Fayyad-Kazan, H.
Mokbel, M.
Nasreddine, M.
Badran, B.
Kchour, G.
CLINICA CHIMICA ACTA, 2024, 558
[29] Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments
Gisbert, J. P.
Romano, M.
Gravina, A. G.
Solis-Munoz, P.
Bermejo, F.
Molina-Infante, J.
Castro-Fernandez, M.
Ortuno, J.
Lucendo, A. J.
Herranz, M.
Modolell, I.
del Castillo, F.
Gomez, J.
Barrio, J.
Velayos, B.
Gomez, B.
Dominguez, J. L.
Miranda, A.
Martorano, M.
Algaba, A.
Pabon, M.
Angueira, T.
Fernandez-Salazar, L.
Federico, A.
Marin, A. C.
McNicholl, A. G.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (08) : 768 - 775
[30] Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes
Sung Eun Kim
Moo In Park
Seun Ja Park
Won Moon
Jae Hyun Kim
Kyoungwon Jung
Hae Koo Kim
Young Dal Lee
World Journal of Gastroenterology, 2017, (06) : 1059 - 1066

← 1 2 3 4 5 →